168 related articles for article (PubMed ID: 19153595)
1. The TAK1-JNK cascade is required for IRF3 function in the innate immune response.
Zhang B; Li M; Chen L; Yang K; Shan Y; Zhu L; Sun S; Li L; Wang C
Cell Res; 2009 Apr; 19(4):412-28. PubMed ID: 19153595
[TBL] [Abstract][Full Text] [Related]
2. Hypothiocyanous Acid Suppresses PolyI:C-Induced Antiviral Responses by Modulating IRF3 Phosphorylation in Human Airway Epithelial Cells.
Nguyen TT; Suzuki S; Sugamata R; Ito F; Tran DH; Yamamoto T; Kawachi S; Suzuki K
Tohoku J Exp Med; 2018 Jun; 245(2):131-140. PubMed ID: 29962372
[TBL] [Abstract][Full Text] [Related]
3. Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β.
Bakshi S; Taylor J; Strickson S; McCartney T; Cohen P
Biochem J; 2017 Mar; 474(7):1163-1174. PubMed ID: 28159912
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.
Nociari M; Ocheretina O; Murphy M; Falck-Pedersen E
J Virol; 2009 May; 83(9):4081-91. PubMed ID: 19211767
[TBL] [Abstract][Full Text] [Related]
5. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Yoshizawa T; Hammaker D; Sweeney SE; Boyle DL; Firestein GS
J Immunol; 2008 Sep; 181(5):3252-8. PubMed ID: 18713996
[TBL] [Abstract][Full Text] [Related]
6. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts.
McWhirter SM; Fitzgerald KA; Rosains J; Rowe DC; Golenbock DT; Maniatis T
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):233-8. PubMed ID: 14679297
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes.
Ikeda F; Hecker CM; Rozenknop A; Nordmeier RD; Rogov V; Hofmann K; Akira S; Dötsch V; Dikic I
EMBO J; 2007 Jul; 26(14):3451-62. PubMed ID: 17599067
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK.
Wang RP; Zhang M; Li Y; Diao FC; Chen D; Zhai Z; Shu HB
Mol Immunol; 2008 Apr; 45(7):1926-34. PubMed ID: 18068231
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3.
Kopp A; Buechler C; Bala M; Neumeier M; Schölmerich J; Schäffler A
Endocrinology; 2010 Mar; 151(3):1097-108. PubMed ID: 20130114
[TBL] [Abstract][Full Text] [Related]
10. C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform.
Pawate S; Bhat NR
Antioxid Redox Signal; 2006; 8(5-6):903-9. PubMed ID: 16771680
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation.
McCoy CE; Carpenter S; Pålsson-McDermott EM; Gearing LJ; O'Neill LA
J Biol Chem; 2008 May; 283(21):14277-85. PubMed ID: 18356163
[TBL] [Abstract][Full Text] [Related]
12. MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis.
Seo M; Lee SO; Kim JH; Hong Y; Kim S; Kim Y; Min DH; Kong YY; Shin J; Ahn K
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14390-14395. PubMed ID: 27911820
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
[TBL] [Abstract][Full Text] [Related]
14. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
Li DD; Wang LL; Deng R; Tang J; Shen Y; Guo JF; Wang Y; Xia LP; Feng GK; Liu QQ; Huang WL; Zeng YX; Zhu XF
Oncogene; 2009 Feb; 28(6):886-98. PubMed ID: 19060920
[TBL] [Abstract][Full Text] [Related]
15. Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis.
Hammaker D; Boyle DL; Firestein GS
Rheumatology (Oxford); 2012 Apr; 51(4):610-8. PubMed ID: 21613249
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells.
Yang K; Shi H; Qi R; Sun S; Tang Y; Zhang B; Wang C
Mol Biol Cell; 2006 Mar; 17(3):1461-71. PubMed ID: 16394098
[TBL] [Abstract][Full Text] [Related]
17. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of endogenous regulation of the type I interferon response by suppressor of IκB kinase epsilon (SIKE), a novel substrate of TANK-binding kinase 1 (TBK1).
Marion JD; Roberts CF; Call RJ; Forbes JL; Nelson KT; Bell JE; Bell JK
J Biol Chem; 2013 Jun; 288(25):18612-23. PubMed ID: 23649622
[TBL] [Abstract][Full Text] [Related]
19. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β.
Gleason CE; Ordureau A; Gourlay R; Arthur JSC; Cohen P
J Biol Chem; 2011 Oct; 286(41):35663-35674. PubMed ID: 21862579
[TBL] [Abstract][Full Text] [Related]
20. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
